Back to results
US 2024/0174681 A1Published application
Salt and crystalline forms of fgfr4 inhibitor and uses thereof
AssigneeBetta Pharmaceuticals Co., Ltd.
InventorsJinheng GAO, Xiaofeng XU, Liang CHEN, Zhongxin SUN, Yun ZHANG, Xiangyong LIU, Lieming DING, Jiabing WANG
Life of this patent
Estimating the term…
Abstract
The present invention relates to a crystalline form and/or maleate, phosphate, L-tartrate, and adipate of the compound represented by the structural formula I, and various crystalline forms of various salt forms, and preparation methods and applications thereof.
Claims30
A crystal form, a salt form and a crystal form of the salt form of a compound represented by Formula I
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
26-30. (canceled)
Dependencies are inferred from the claim text.